The abrupt halt of operational communications by the U.S Department of Health and Human Services (HHS), as ordered by the Trump administration until at least February 1, 2025, attracted an immediate influx of shock, anger and disbelief among healthcare professionals, public health officials and infection prevention specialists. As the Lead Editor of Infection Control Today,…
The recent directive in the United States, which effectively ended the Centers for Disease Control's (CDC) collaboration with the World Health Organization (WHO), has raised significant concerns within the global infection prevention and control (IPC) field.
This sudden policy shift abruptly concluded a pivotal data exchange, which severely impacts IPC professionals' ability to access real-time epidemiological…
This article focuses on the challenges contributing to increased pathogen resistance to antimicrobial drugs in Guyana, with a particular emphasis on the private market for such drugs in selected mining and frontier regions. The investigation of this issue involved an extensive survey of both authorized and unauthorized private sector suppliers, encompassing everything from official pharmacies…